Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The privately held company first filed for approval of the drug in September 1999 but the New Drug Application was rejected by the FDA in 2002
2018 Jan 31;10(2):160
) Weight-related diagnoses (Blood pressure, prediabetes, type 2 diabetes, lipids, sleep apnea, fatty liver disease, cardiovascular history) Prior weight-loss attempts (your lifestyle, nutrition, medications, structured interventions) Relevant medical history (pancreatitis, gallbladder disease, severe GI motility disorders, personal or family history of medullary thyroid cancer or MEN2, pregnancy, or plans for pregnancy) Why it works: GLP-1 medications are indicated for adults with a BMI 30, or a BMI 27 with at least one weight-related condition
Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, De ZH, et al
Conflicts of interest There are no conflicts of interest
Manufactured under strict quality standards and formulated with 0.9% benzyl alcohol as a preservative, this multi-dose solution is designed to maintain product stability and sterility during laboratory use
